Our global facilities are configured with the necessary controls required for the handling and processing of highly potent molecules.
We offer a global solution from early-phase formulation screening through clinical and commercial manufacturing.
As customers look for therapies that have greater selectivity and pharmacological activity, we can meet the challenge.
Responding to the challenges of HPAPI's, like in Oncology, our facilities are capable to perform at their maximum.
Especially true in the oncology sector, HPAPIs present an array of additional of chemistry, manufacturing, and control (CMC) challenges. We have responded to the challenges by ensuring our facilities are capable of handling compounds with a maximum performance-based level of exposure classification.
From early-phase formulation screening through clinical and commercial manufacturing we can help accelerate your highly potent molecule development with our end-to-end, integrated approach. When you need commercial manufacturing for a simple or complex drug product, we can help.
If you have any questions relating to how we handle HPAPIs please don't hesitate to 'Get in touch' with our team of scientific experts who will be happy to assist you with your highly-potent drug development challenges.
Integrated development platform that is proven to reduce timelines by >12 months.
Simple & complex dosage forms: PIB, PIC, Tablets, Poorly Soluble, Modified-Release, Pediatrics.
Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions, molecules need to become cures, fast. Because humanity needs solutions, fast.
Our scientists can help you overcome the drug delivery challenges presented by your molecule for all dosage forms and routes of delivery.
Get in touch
